Bioequivalence study of voriconazole for intravenous infusion in healthy Chinese subjects under fasting conditions

Voriconazole, a second-generation triazole, is used to prevent and treat invasive fungal infections. This study aimed to assess the bioequivalence and safety of test and reference voriconazole intravenous infusion under the fasting conditions. The study employed a randomized, open-label, single-dose...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of pharmaceutical sciences Vol. 114; no. 2; p. 1385
Main Authors:	Xiang, Zhangqiang, Li, Mupeng, Cui, Shaoting, Gan, Chunyan, Liu, Fangfang, Huang, Qian, Mai, Gang, Fan, Lianlian
Format:	Journal Article
Language:	English
Published:	United States 01.02.2025
Subjects:	Adult Antifungal Agents - administration & dosage Antifungal Agents - adverse effects Antifungal Agents - blood Antifungal Agents - pharmacokinetics Area Under Curve Asian People Cross-Over Studies East Asian People Fasting - blood Female Healthy Volunteers Humans Infusions, Intravenous Male Middle Aged Tandem Mass Spectrometry - methods Therapeutic Equivalency Voriconazole - administration & dosage Voriconazole - adverse effects Voriconazole - blood Voriconazole - pharmacokinetics Young Adult Safety Bioequivalence Pharmacokinetics Chinese subjects Voriconazole
ISSN:	1520-6017, 1520-6017
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!